Hot Stock Alerts

Follow Me
Follow Me

Real Time Stocks

VRA, APSG, MRNA, CRIS, FEIC – Notable Stocks with Volume at NASDAQ

Sunday, January 2, 2011 @ 09:01 AM
posted by Mattew12

Vera Bradley, Inc. (Public, NASDAQ:VRA) decreased -2.91%, to close at $33.00 and its overall traded volume was 216,304.00 shares during the last session against its average volume of 303,218.00. VRA opened the day at $34.00, it made an intraday low of $32.51 and an intraday high of $34.30. The stock has a 52 week low of $22.00 and 52 week high of $41.01. VRA’s market capitalization is 1.34B and it has 40.51M outstanding shares.

About Vera Bradley, Inc. (Public, NASDAQ:VRA)

Vera Bradley, Inc. (Vera Bradley) is a designer, producer, marketer and retailer of accessories for women. The products include offering of handbags, accessories, and travel and leisure items. The Company operates in two segments: Indirect and Direct. As of May 1, 2010, the Indirect business consisted of sales of Vera Bradley products to approximately 3,300 independent retailers, substantially all of which are located in the United States, as well as to select national retailers and independent e-commerce sites. The Indirect business consists of a network of over 3300 independent retailers. As of May 1, 2010, the Company operated 28 full-price stores in 19 states throughout the United States.


Applied Signal Technology, Inc. (Public, NASDAQ:APSG) increased 0.00%, to close at $37.89 and its overall traded volume was 216,268.00 shares during the last session against its average volume of 777,311.00. APSG opened the day at $37.89, it made an intraday low of $37.89 and an intraday high of $37.91. The stock has a 52 week low of $17.08 and 52 week high of $37.93. APSG’s market capitalization is 507.58M and it has 13.40M outstanding shares.

About Applied Signal Technology, Inc. (Public, NASDAQ:APSG)

Applied Signal Technology, Inc. (AST) is a provider of intelligence, surveillance and reconnaissance (ISR) solutions. The Company operates in four divisions: Broadband Communication Systems, Intelligence and Electronic Warfare Systems, Network Intelligence and Sensor Systems. The Company provides domain knowledge in the areas of communications, signals intelligence (SIGINT) and sensor signature processing. The Company’s SIGINT comprises the collection and exploitation of communications intelligence, electronic intelligence and cyber intelligence. AST’s sensor signature activity includes processing information from electro-optic, sonar, radar, magnetic, and chemical sensors to detect changes in the environment and provide real-time alerts of potential threats. AST is engaged in the collection, processing and understanding of signals for ISR missions with low size, weight and power configurations to enable deployment on unmanned platforms. In April 2010, the Company acquired Seismic LLC.


Marina Biotech, Inc. (Public, NASDAQ:MRNA) increased 1.31%, to close at $1.55 and its overall traded volume was 215,340.00 shares during the last session against its average volume of 245,859.00. MRNA opened the day at $1.50, it made an intraday low of $1.50 and an intraday high of $1.57. The stock has a 52 week low of $1.31 and 52 week high of $7.48. MRNA’s market capitalization is 39.33M and it has 25.39M outstanding shares.

About Marina Biotech, Inc. (Public, NASDAQ:MRNA)

Marina Biotech Inc, formerly MDRNA, Inc., is a biotechnology company focused on the discovery, development and commercialization of pharmaceuticals based on RNA interference (RNAi). Its infrastructure provides for pre-clinical scale manufacturing of both siRNAs and delivery materials, the analysis and optimization of these compounds both individually and as drug candidates, and the filing of Investigational New Drug Applications. The Company develops RNAi-based product candidates for the treatment of cancer, metabolic disorders, inflammation, and viral infections. It focuses on siRNA constructs, such as dicer substrates and three-stranded meroduplexes, and delivery systems for improved siRNA delivery. MDRNA’s various development programs consist of oncology; metabolic disorders, and inflammation.


Curis, Inc. (Public, NASDAQ:CRIS) decreased -1.98%, to close at $1.98 and its overall traded volume was 215,031.00 shares during the last session against its average volume of 281,224.00. CRIS opened the day at $2.02, it made an intraday low of $1.96 and an intraday high of $2.05. The stock has a 52 week low of $1.21 and 52 week high of $3.70. CRIS’s market capitalization is 149.76M and it has 75.64M outstanding shares.

About Curis, Inc. (Public, NASDAQ:CRIS)

Curis, Inc. is a drug discovery and development company committed to leveraging signaling pathway drug technologies in seeking to develop targeted cancer therapies. The Company conducts its research programs both internally and through strategic collaborations. Its advanced program is Hedgehog pathway inhibitor program under collaboration with Genentech, Inc., a wholly owned member of the Roche Group. The lead drug candidate being developed under this program is GDC-0449, an orally-administered small molecule Hedgehog pathway inhibitor. The Hedgehog pathway is normally active during embroyonic development and regulates tissue and organ formation.


FEI Company (Public, NASDAQ:FEIC) decreased -0.68%, to close at $26.41 and its overall traded volume was 214,759.00 shares during the last session against its average volume of 249,082.00. FEIC opened the day at $26.53, it made an intraday low of $26.28 and an intraday high of $26.62. The stock has a 52 week low of $16.51 and 52 week high of $26.79. FEIC’s market capitalization is 1.01B and it has 38.23M outstanding shares.

About FEI Company (Public, NASDAQ:FEIC)

FEI Company is a supplier of instruments for nanoscale imaging, analysis and prototyping to enable research, development and manufacturing in a range of industrial, academic and research institutional applications. The Company’s products and systems include focused ion beam systems (FIBs), scanning electron microscopes (SEMs), transmission electron microscopes (TEMs) and DualBeam systems, which combine a FIB and SEM on a single platform. The Company’s DualBeam systems include models that have wafer handling capability that are purchased by semiconductor and data storage manufacturers (wafer-level DualBeam systems) and models that have small stages and are sold to customers in several markets (small-stage DualBeam systems). The Company’s sales and service operations are conducted in the United States and approximately 50 other countries worldwide. In June 2009, FEI Company acquired the Mineral Liberation Analysis business of JKTech Pty Ltd.

Share and Enjoy:
  • Twitter
  • email
  • Print
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google Bookmarks
  • Blogplay
  • StumbleUpon
  • Technorati
  • Add to favorites
  • Yahoo! Bookmarks
  • PDF
  • Reddit
  • Live
  • RSS
Rating 3.00 out of 5
[?]

Leave a Reply

Google Analytics Alternative